UPDATE: Cowen Downgrades Orchard Therapeutics (ORTX) to Market Perform
Tweet Send to a Friend
(Updated - March 31, 2022 3:37 AM EDT)
Cowen analyst Yaron Werber downgraded Orchard Therapeutics (NASDAQ: ORTX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Yaron Werber downgraded Orchard Therapeutics (NASDAQ: ORTX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
